Posts by Noëlle Aubert

The eyeWatch system is the world’s first adjustable system for treating glaucoma   The first patient in Valais has benefited from an innovative device for the treatment of glaucoma, the eyeWatch. This new technology was developed by the Swiss ophthalmology network Swiss Visio, in collaboration with the EPFL and Rheon Medical. The eyeWatch device is the…

The critical role of the immune system in the fight against cancer   UNIGE Researchers have developed in vitro tumour models that incorporate components of the tumour and elements of the patient’s immune system to test the effectiveness of treatments.   Every tumour is different, every patient is different. So how do we know which…

Geneva as a center for global public health development   Initially launched in the United States, Baraka relocated to Geneva earlier this year, with the support of Greater Geneva Bern area (GGBa) and the Geneva investment promotion team (DG DERI).   Baraka Impact Finance enables companies that are developing solutions for global health challenges in…

1st closing round of CHF 2.3 million   EarlySight is delighted to announce the first closing of CHF 2.3 million out of a CHF 3 million seed funding round. The start-up, which was founded in March 2019, uses a novel approach to provide a single cell level imaging of the back of the eye, called…

One of the Best Workplaces™ Switzerland for fourth straight year   Selexis SA, a JSR Life Sciences company, announced that Great Place to Work® has designated the Company among the “Best Workplaces™ Switzerland” in 2021. Selexis joins companies across a broad range of industries whose employees believe their workplace culture possesses effective leadership, holds meaningful values…

A CHF 50 million incentive programme   The Swiss Confederation hopes to contribute to making Switzerland a place of research and development of vaccines in anticipation of possible future pandemics. On 19 May 2021, the Federal Council approved the creation of a CHF 50 million incentive programme up to the end of 2022, which is…

Medical devices regulation (MDR): overview   What do exporters need to know about the Medical Devices Regulation (MDR)? The date of application is May 26, at the same time as the corresponding Swiss Ordinance on Medical Devices (MedDO) comes into force. Switzerland Global Enterprise (S-GE)  have collected the most important links for you and are…

Anti-fibrotic therapies targeting long non-coding RNAs   HAYA Therapeutics, SA, a company developing precision medicines that target tissue and cell-specific long non-coding RNAs (lncRNAs), announced the successful closing of its CHF 18 million seed round. The financing was led by Broadview Ventures, with participation from Apollo Health Ventures, BERNINA BioInvest, 4See Ventures, Schroder Adveq and…

Connecting Life Sciences Innovators (CLSI) event On 18 March, 2021 the Medical Applications section of the CERN Knowledge Transfer (KT) group and BioAlps organised the joint online event “Connecting Life Sciences Innovators – Innovate in healthcare with CERN”.  While CERN is known to be the world’s largest particle physics laboratory, this event presented how technological breakthroughs developed…

Accelerate the innovation of start-ups established at Biopôle    Biopôle SA, a privately held Swiss not-for-profit organisation that manages and promotes the Biopôle life sciences campus in Lausanne, is thrilled to announce the launch of a new fund dedicated to supporting the next generation of impact-driven life sciences entrepreneurs. With an annual budget of approximately CHF 500,000,…